Abstract:Background: Genome alterations need to be investigated before clinical application of iPS cells. Results: Reprogramming and gene targeting can generate substantial but different genomic variations. Conclusion: Stringent genomic monitoring and selection are needed both at the time of iPSC derivation and after gene targeting. Significance: This study examined the genome instability during iPSC generation and subsequent gene correction and revealed different genome alterations at each step.The generation of personalized induced pluripotent stem cells (iPSCs) followed by targeted genome editing provides an opportunity for developing customized effective cellular therapies for genetic disorders. However, it is critical to ascertain whether edited iPSCs harbor unfavorable genomic variations before their clinical application. To examine the mutation status of the edited iPSC genome and trace the origin of possible mutations at different steps, we have generated virus-free iPSCs from amniotic cells carrying homozygous point mutations in -hemoglobin gene (HBB) that cause severe -thalassemia (-Thal), corrected the mutations in both HBB alleles by zinc finger nuclease-aided gene targeting, and obtained the final HBB gene-corrected iPSCs by excising the exogenous drug resistance gene with Cre recombinase. Through comparative genomic hybridization and whole-exome sequencing, we uncovered seven copy number variations, five small insertions/deletions, and 64 single nucleotide variations (SNVs) in -Thal iPSCs before the gene targeting step and found a single small copy number variation, 19 insertions/deletions, and 340 single nucleotide variations in the final gene-corrected -Thal iPSCs. Our data revealed that substantial but different genomic variations occurred at factor-induced somatic cell reprogramming and zinc finger nuclease-aided gene targeting steps, suggesting that stringent genomic monitoring and selection are needed both at the time of iPSC derivation and after gene targeting.

Reprogramme-induced genomic stability

Unique Features of Mutations Revealed by Sequentially Reprogrammed Induced Pluripotent Stem Cells

Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells

Chromosomal aberration arises during somatic reprogramming to pluripotent stem cells

Enhancement of Xrcc1-mediated Base Excision Repair Improves the Genetic Stability and Pluripotency of Ipscs

Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors.

The genomic stability of induced pluripotent stem cells

Effects of Reprogramming on Genomic Imprinting and the Application of Pluripotent Stem Cells

Chromosome Microduplication in Somatic Cells Decreases the Genetic Stability of Human Reprogrammed Somatic Cells and Results in Pluripotent Stem Cells

Genome-wide CNV Analysis in Mouse Induced Pluripotent Stem Cells Reveals Dosage Effect of Pluripotent Factors on Genome Integrity

Methods of Reprogramming to Induced Pluripotent Stem Cell Associated with Chromosomal Integrity and Delineation of a Chromosome 5q Candidate Region for Growth Advantage

Abnormalities in Human Pluripotent Cells Due to Reprogramming Mechanisms

Progress and Bottleneck in Induced Pluripotency.

Genetic heterogeneity of induced pluripotent stem cells: results from 24 clones derived from a single C57BL/6 mouse

Incomplete reprogramming of DNA replication timing in induced pluripotent stem cells

Human Induced Pluripotent Stem Cells: From Cell Origin, Genomic Stability, and Epigenetic Memory to Translational Medicine

Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in Β-Thalassemia Induced Pluripotent Stem Cells (Ipscs).

Reprogramming mechanism and genetic stability of induced pluripotent stem cells (iPSCs)

Residual expression of reprogramming factors affects the transcriptional program and epigenetic signatures of induced pluripotent stem cells

Low Incidence of DNA Sequence Variation in Human Induced Pluripotent Stem Cells Generated by Nonintegrating Plasmid Expression.

Human Induced Pluripotent Cells Resemble Embryonic Stem Cells Demonstrating Enhanced Levels of Dna Repair and Efficacy of Nonhomologous End-Joining